English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR+
  • Contact
  • Careers
  • English
  • Français

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • 2023 Annual Meeting
    • 2022 Annual Meeting
    • 2021 Annual Meeting
    • 2020 Annual Meeting
    • 2021 Special Meeting
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Presentation
  • Financial Results
  • Stock Data
    • TSX: MDP
    • OTCQX: MEDXF
    • Analyst Coverage
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEDAR+
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • 2023 Annual Meeting
  • 2022 Annual Meeting
  • 2021 Annual Meeting
  • 2020 Annual Meeting
  • 2021 Special Meeting
Jan 21, 2021 8:30am EST

Medexus Submits Application to List on the Nasdaq

Jan 06, 2021 5:00pm EST

Medexus Engages Independent Trading Group for Market Making Services

Jan 04, 2021 4:30pm EST

Medexus Pharmaceuticals to Present at the SNN Network Canada Virtual Event on Thursday, January 7, 2021

Dec 21, 2020 5:30pm EST

Medexus Announces Annual Equity Incentive Grants to Non-Executive Directors

Dec 18, 2020 8:30am EST

Medexus Enters into Exclusive License to Register and Commercialize Triamcinolone Hexacetonide (TH) in the United States with Ethypharm

Dec 08, 2020 8:30am EST

Medexus to Present at The 13th Annual LD Micro Main Event Conference on December 15th

Dec 02, 2020 8:30am EST

Medexus to Webcast Live at VirtualInvestorConferences.com December 3rd

Nov 16, 2020 5:15pm EST

Medexus Pharmaceuticals Reports Operating and Financial Results for the Three- and Six-Month Periods Ending September 30, 2020

Nov 16, 2020 8:00am EST

Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients

Nov 09, 2020 8:30am EST

Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2021 Conference Call

RSS
  • Previous
    • 1...
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2023 Medexus Pharmaceuticals, Inc.
    All Rights Reserved.
    Facebook Facebook
    Privacy Policy Disclaimer Sitemap

    Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.